ENDO USA, Inc.: Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single
Recall reason: Crystallization; identified as Buprenorphine free base. Recalled by ENDO USA, Inc.. Distribution: USA Nationwide. Classification (Class II — potential health risk). Affected lots/NDC/dates: Lot #: 84132, Exp 02/28/2027; 87693, Exp 03/31/2027. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report